MedTrace Logo

The Efficacy and Safety Study of CAR-T Cells for Functional Cure in HIV-1/AIDS Patients

NCT06880380 · Status: RECRUITING · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 3

Last updated 2026-03-05

No results posted yet for this study

Summary

Autologous CAR-T cell therapy in HIV-1/AIDS patients

Conditions

  • HIV Infected Individuals
  • HIV

Interventions

BIOLOGICAL

HIV-CAR-T

Intravenous Infusion of CAR-T Cells

Sponsors & Collaborators

  • Tsinghua University

    collaborator OTHER

  • Institute of Hematology & Blood Diseases Hospital, China

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-09-01
Primary Completion
2026-03-31
Completion
2026-07-01

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06880380 on ClinicalTrials.gov